Aquilon Pharmaceuticals (SA)
Active
VAT
BE 0540.870.218
Address
Rue Porte De Lorette(VIS) 76
4600
Visé
Established
14-10-2013
Principal activity
Research and experimental development on biotechnology
Crisis resilience of Aquilon Pharmaceuticals
Which companies are best armed against current economic trends and the energy crisis?
Read moreFinancial data of Aquilon Pharmaceuticals
2023
|
2022
|
2021
|
2020
|
||||
|---|---|---|---|---|---|---|---|
| Profit/Loss | -€936,675 | -23% |
-€762,477 | -21% |
-€629,068 | -412% |
€201,400 |
| Equity | €1,863,008 | 145% |
€760,758 | -50% |
€1,523,235 | -29% |
€2,152,303 |
| Gross margin | €917,235 | 103% |
€451,097 | 190% |
€155,329 | -93% |
€2,332,566 |
| Employees | 9,2 FTE | 12% |
8,2 FTE | 17% |
7 FTE | 49% |
4,7 FTE |
Publications in the Belgian Official Journal for Aquilon Pharmaceuticals
Frequently asked questions
What is the VAT number of Aquilon Pharmaceuticals?
The VAT number of Aquilon Pharmaceuticals is BE0540870218.
When was Aquilon Pharmaceuticals founded?
Aquilon Pharmaceuticals was founded on 14-10-2013.
What is the address of Aquilon Pharmaceuticals?
The current registered office of Aquilon Pharmaceuticals is located at Rue Porte De Lorette(VIS) 76, 4600 Visé.
When was the last time Aquilon Pharmaceuticals filed their annual financial statements?
The most recent financial statements of Aquilon Pharmaceuticals were filed on 07-10-2024. You can view them here.
How many employees does Aquilon Pharmaceuticals have?
There are 9,2 FTEs working at Aquilon Pharmaceuticals according to the staff figures in the most recent financial statements.
What is the annual turnover of Aquilon Pharmaceuticals?
At the time of its most recent financial statements, Aquilon Pharmaceuticals did not publish any turnover figures. Aquilon Pharmaceuticals reported a gross margin of €917,235.25.
